Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant610 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00279058 | The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2 | completed | Phase 1 / Phase 2 | 24 | Hadassah Medical OrganizationOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT00029900 | ADI-PEG in Patients With Metastatic Melanoma | completed | Phase 1 | 15 | FDA Office of Orphan Products DevelopmentFED | 1 | Mar 25, 2015 | clinicaltrials |
| NCT00668512 |
| Intratumoral Injection Of Alpha-Gal Glycosphingolipids |
| completed |
| Phase 1 |
| 12 |
| University of Massachusetts, WorcesterOTHER |
| 1 |
| Mar 19, 2015 |
| clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT01127594 | Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion | completed | Phase 1 | 29 | Douglas TylerOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT01752257 | EF5 in Melanoma Patients | completed | Phase 1 | 15 | Douglas TylerOTHER | 1 | Mar 9, 2015 | clinicaltrials |
| NCT00565968 | Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg | completed | Phase 1 | 20 | Duke UniversityOTHER | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00441337 | A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies(MDX1106-01) | completed | Phase 1 | 39 | Bristol-Myers SquibbINDUSTRY | 1 | Feb 20, 2015 | clinicaltrials |
| NCT00412828 | A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | 117 | CuraGen CorporationINDUSTRY | 1 | Feb 19, 2015 | clinicaltrials |
| NCT00124124 | Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine | completed | Phase 1 | 50 | Dr. Nina BhardwajINDIV | 1 | Feb 13, 2015 | clinicaltrials |
| NCT00085488 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 | — | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT02350972 | Inducing Systemic Immunity and Regressions in Metastatic Melanoma | completed | Phase 1 | 88 | NYU Langone HealthOTHER | 0 | Jan 30, 2015 | clinicaltrials |
| NCT01989559 | Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01386580 | An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. | completed | Phase 1 / Phase 2 | 84 | BBB-Therapeutics B.V.INDUSTRY | 4 | Jan 22, 2015 | clinicaltrials |
| NCT01462773 | Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma | completed | Phase 1 | 16 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 13, 2015 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00003224 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 22 | University of VirginiaOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT00089219 | Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma | completed | Phase 1 / Phase 2 | 39 | University of VirginiaOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT01247623 | Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma | completed | Phase 1 / Phase 2 | — | Oslo University HospitalOTHER | 1 | Nov 5, 2014 | clinicaltrials |
| NCT01489059 | Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma | completed | Phase 1 | 42 | Bristol-Myers SquibbINDUSTRY | 2 | Aug 29, 2014 | clinicaltrials |
| NCT00710515 | Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies | completed | Phase 1 | 30 | AstraZenecaINDUSTRY | 2 | Aug 13, 2014 | clinicaltrials |
| NCT00003750 | Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors | completed | Phase 1 | 28 | Children's Oncology GroupNETWORK | 3 | Aug 8, 2014 | clinicaltrials |
| NCT02203864 | Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma | completed | Phase 1 | 49 | Boehringer IngelheimINDUSTRY | 0 | Jul 31, 2014 | clinicaltrials |
| NCT00920907 | Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma | completed | Phase 1 | 99 | Bristol-Myers SquibbINDUSTRY | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00025181 | Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00028431 | Novel Adjuvants for Peptide-Based Melanoma Vaccines | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01339663 | Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 12 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00349206 | Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma | completed | Phase 1 | 69 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2014 | clinicaltrials |
| NCT00356460 | Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma | completed | Phase 1 | 29 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00084214 | STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma | completed | Phase 1 / Phase 2 | 103 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Mar 6, 2014 | clinicaltrials |
| NCT00313508 | Dendritic Cell Vaccination During Lymphoid Reconstruction | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 21, 2014 | clinicaltrials |
| NCT00012064 | Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma | completed | Phase 1 / Phase 2 | 56 | Lisata Therapeutics, Inc.INDUSTRY | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00672542 | Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells | completed | Phase 1 | 12 | Scott PruittOTHER | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00796991 | Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine | completed | Phase 1 | 72 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00597038 | A Phase I/II Study of Dasatinib and Dacarbazine | completed | Phase 1 / Phase 2 | 50 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00007969 | Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | — | QLT Inc.INDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00002952 | Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | 20 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01743157 | Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma(BBI) | completed | Phase 1 / Phase 2 | 24 | California Pacific Medical Center Research InstituteOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00246012 | A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma | completed | Phase 1 / Phase 2 | 144 | Centocor, Inc.INDUSTRY | 3 | Aug 19, 2013 | clinicaltrials |
| NCT00815607 | Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma | completed | Phase 1 | 12 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT01011530 | Dose Escalation Study of MLN4924 in Adults With Melanoma | completed | Phase 1 | 37 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00003022 | Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00948467 | Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies | completed | Phase 1 | 51 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00003792 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 1 | — | Baylor Health Care SystemOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00039572 | Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain | completed | Phase 1 / Phase 2 | — | Beth Israel Deaconess Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00019214 | Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00058279 | Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 21, 2015source: clinicaltrials